[Therapeutic effect of anti interleukin-18 antibody in the adriamycin-induced modal of minimal-change nephrotic syndrome].
Chen
Shan-lin
SL
Wang
Cai-xia
CX
Xiao
Lin-sheng
LS
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004317:Doxorubicin / Q000633:toxicity; D007167:Immunotherapy; D020382:Interleukin-18 / Q000276:immunology* / Q000494:pharmacology; D008297:Male; D051379:Mice; D009402:Nephrosis, Lipoid / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy
D000888:Antibodies, Anti-Idiotypic; D020382:Interleukin-18; D004317:Doxorubicin